Page results
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
File results
-
FOI/2023/0474 - Number of live births, still births and neonatal deaths
-
FOI/2023/0475 - Agency usage for the decontamination department
-
FOI/2023/0476 - Single longest wait in A&E for mental health related issue
-
FOI/2023/0478 - Social media management platform
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI/2023/0485 - Heart attacks 2019/22
-
FOI/2023/0487 - Maintenance of corporate estate
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer